{"adverse_reactions":["Sincerus Florida, LLC adverse reactions dsfd"],"components":["Actives, inactives dwsd"],"effective_time":"20190503","id":"87fef62f-e3c2-a78a-e053-2995a90a96ca","instructions_for_use":["Directions for use ww"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1152-2. NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5% / TRETINOIN USP 0.025%. Gel30gm. ww"],"set_id":"87fef62f-e3c1-a78a-e053-2995a90a96ca","spl_product_data_elements":["NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.025% NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.025% NIACINAMIDE NIACINAMIDE SPIRONOLACTONE SPIRONOLACTONE TRETINOIN TRETINOIN"],"version":"1"}